• Edifici M planta 1ª torre M1

    08193 Bellaterra (Cerdanyola del Vallès)

Calculated based on number of publications stored in Pure and citations from Scopus
1996 …2023

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

General quality indicators of scientific research

Research Accreditation (CNEAI):1996-01, 2002-07, 2008-13, 2014-19.  Teaching Accreditation (ANECA): 1997-01, 2002-6, 2007-11, 2012-16, 2017-21. Research Accreditation (AQU/Generalitat Catalunya): 1996-01, 2002-07, 2008-13, 2014-19. Accrediation Full Professor (ANECA): 2018.

H-Index:32. Total citations (Scopus & Web of Science/Publons): 3700. Citations (Scopus): 2017: 204, 2018:187, 2019:207, 2020:229, 2021:300, 2022: 218

Research interests

Dr. Saura obtained his Ph.D. in Chemistry/Biochemistry and Molecular Biology from University of Barcelona, and then performed postdoctoral training at the Dpt of Pathology of the Johns Hopkins University and Department of Neurobiology at the University of Chicago (1998-99). In 2000, he was appointed Instructor Professor at the Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School (USA). Under Prof. J. Shen mentoring, Dr. Saura investigated cellular and molecular mechanisms underlying memory loss and neurodegeneration in novel transgenic and knockout mouse models of Alzheimer’s disease (AD), studies published as first author papers in Neuron (2001,2004) and J. Neurosci (2005).  In 2004, Dr. Saura was recruited as a Ramón y Cajal Research Fellow at the Universitat Autònoma de Barcelona, where he is currently Associate Professor at the Dpt Biochemistry and Molecular Biology. Dr. Saura’s lab (www.sauralab.com) at Institut de Neurociències-UAB (https://inc.uab.cat/en) is recognized as Excellent research group from Generalitat de Catalunya (2021 SGR0142) and is a member of the Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED)-Instituto Carlos III. Dr. Saura

Dr. Saura’s scientific interest is focused on cellular and molecular mechanisms of brain function and dysfunction in cognitive disorders, particularly Alzheimer’s disease (AD). His lab uses novel transcriptomic, brain imaging and chemogenetic approaches  to understand the transcriptomic mechanisms underlying synaptic changes in neurodegeneration and AD. Saura lab’s studies have been published in Neuron, Biol Psychiatry, eLife, J. Neurosci, Small, Sci. Reports, and reviewed in seminal reviews in Front Neurosci (2015, 2020), Trends Neurosci (2017), Biol Psychiatry (2019), and Semin Cell Dev Biol (2023). Dr. Saura has coauthored 64 peer-reviewed manuscripts with 3700 citations (Scopus/Web of Science/Publons; 125 citations/year),and is Review Editor for Front Mol Neurosci and Front Neurogenetics.

Dr. Saura has coordinated several national and international research projects (2.5 million € last 10 years) and collaborates with national and international funding agencies and scientific journals. Dr. Saura acts as grant reviewer for the Alzheimer’s Association, Instituto Carlos III, Spanish Research Agency (AEI), Agence Nationale de la Recherche (ANR)- France, Romanian National Research Council, Fundación Ikerbasque, Junta de Andalucía, and has participated as pannelist of Ramón y Cajal Program (2017, 2021 vice-president), and Biomedicine Research Grants (2012, 2015, 2017; Manager: 2019, 2020; President: 2021, 2022, 2023). Dr. C. Saura was member of the Directive Board of the Institut de Neurociències-UAB (2009-17), Scientific Advisor Committee of Araclon Biotech SL (Grifols; 2009-11), Directive Board/Treasurer of the Sociedad Española de Neurociencia  (2015-19), and is Coordinator of the Neurobiology Section-Societat Catalana de Biologia (2015-23). Dr. Saura was appointed Manager (2018-20) and Coordinator (2020-23) of the Biomedicine/Nervous System Diseases Grant Program at AEI.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 7 - Affordable and Clean Energy

Education/Academic qualification

Ph. D., Doctorado, Universitat de Barcelona (UB)

Award Date: 15 Jan 1998

Masters, Bioquímica y Biologia Molecular, Universitat de Barcelona (UB)

1 Sept 19931 Jul 1995

Award Date: 1 Jul 1995

Degree, Química, Universitat de Barcelona (UB)

Award Date: 1 Jul 1993

External positions

Investigador Ramón y Cajal, Universitat Autònoma de Barcelona (UAB)

1 Apr 20041 Apr 2009

Profesor Associado en Neurologia, Harvard Medical School

1 Apr 20001 Apr 2004

Investigador postdoctoral, University of Chicago

1 Apr 19991 Apr 2000

Investigador postdoctoral, Johns Hopkins University (JHU)

15 Mar 199830 Mar 1999

Estudiante de doctorado, Universitat de Barcelona (UB)

1 Sept 199415 Jan 1998

Máster en Bioquímica y Biologia Molecular, Universitat de Barcelona (UB)

1 Sept 199315 Jul 1994

Becario Colaboración, Universitat de Barcelona (UB)

1 Jun 199215 Jul 1993


Dive into the research topics where Carlos Alberto Saura Antolin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or